Category Archives: Actos

Featured Stories

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

Colorado Woman Sues American Medical Systems Over Transvaginal Mesh Injuries

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a Colorado woman allegedly injured by transvaginal mesh products manufactured by American Medical Systems, Inc. The suit was filed on May 21, 2012 in the U.S. District Court for the Northern District of California (Case No. ...

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

Research Study Confirms Fracking Cause of Ohio Earthquakes

Research Study Confirms Fracking as Cause of Ohio Earthquakes

Fracking operation near Poland Township, Ohio, activated a previously unknown fault in the, causing 77 earthquakes with magnitudes ranging from 1.0 to 3.0 in March 2014.

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Federal Jury Awards $9 Billion in Damages in Actos Bladder Cancer Case

After deliberating for about four hours yesterday, a federal jury ordered Takeda Pharmaceuticals and Eli Lilly & Co. to pay a combined $9 billion in punitive damages to Terrence Allen, finding that the drug makers hid the bladder cancer risks … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Actos Jury Advised Takeda Officials Hid Cancer Risks


The federal trial that just started and involving Actos, Takeda Pharmaceutical Co.’s Type II diabetes drug, includes allegations that Takeda hid risks associated with Actos from physicians and consumers. The litigation accuses Takeda of hiding risks associated with Actos. Because … Continue reading

Posted in Actos, Pharmaceuticals |

First Bellwether Trial in Actos Multidistrict Litigation Underway


The first federal bellwether trial alleging that the diabetes drug Actos (pioglitazone) caused bladder cancer begins today. The trial is taking place in the U.S. District Court for the Western District of Louisiana before the Honorable Rebecca F. Doherty. The plaintiffs … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Jury Selection Completed in First Actos Bladder Cancer Bellwether Trial


Jury selection was completed on Monday, January 27 in the first bellwether case in the Actos bladder cancer litigation. After pretrial matters January 30, testimony will begin February 3, with the trial expected to last six weeks. This case was … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Actos Maker, Takeda, Hid Drug’s Risks from Patients, Doctors


Another Actos lawsuit alleges that Takeda Pharmaceutical Co., the maker of the Type 2 diabetes drug, put profits before patient safety and “duped” patients. The lawsuit states that Takeda should be held liable in the cancer death of a former … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Florida Man Alleges Serious Injuries After Taking Diabetes Drug, Actos


A Florida man alleges that he developed bladder cancer after taking the Type 2 diabetes drug, Actos (pioglitazone), for nearly seven years. A lawsuit has been filed on behalf of the man and is just one of thousands of lawsuits … Continue reading

Posted in Actos, Pharmaceuticals |

Lawsuit Accuses Actos Makers of Placing Profits Before Patient Safety


A lawsuit alleges that Asia’s largest drug maker, Takeda Pharmaceuticals, put profits before patient safety. Actos (pioglitazone), Takeda’s Type 2 diabetes drug, has been at the center of thousands of personal injury lawsuits. Takeda officials were aware, as far back … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Another Lawsuit Filed Over Allegations that Actos is Tied to Bladder Cancer


Another lawsuit has been filed against the makers of the Type 2 diabetes drug, Actos, over allegations that the medication caused the Oregon man to develop bladder cancer. The lawsuit also alleges that the drug makers were aware of the … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Another Actos User Alleges Bladder Cancer Caused by Type 2 Diabetes Drug


A Florida woman is alleging that taking the Type 2 diabetes drug, Actos (pioglitazone), caused her to develop bladder cancer, according to a lawsuit brought against the maker of the drug, Takeda Pharmaceuticals. The woman began taking Actos from about … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Gum Disease Tied to Increased Diabetes Risk, May Lead to Increased Risks Tied to Some Type 2 Diabetes Drugs


The links between dental disease and other diseases have been growing, for instance dental disease has been tied to increased risks for developing diabetes and heart disease; pregnancy complications; and, potentially, dementia. Type 2 diabetes is typically treated with any … Continue reading

Posted in Actos, Byetta Cancer, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.